Genetics, C. (2026). Confluence Genetics Launches Cas-CLEAR™, a New CRISPR Technology Platform for Cancer Therapy. Business Wire (English).
Chicago Style (17th ed.) CitationGenetics, Confluence. "Confluence Genetics Launches Cas-CLEAR™, a New CRISPR Technology Platform for Cancer Therapy." Business Wire (English) 2026.
MLA (9th ed.) CitationGenetics, Confluence. "Confluence Genetics Launches Cas-CLEAR™, a New CRISPR Technology Platform for Cancer Therapy." Business Wire (English), 2026.
Warning: These citations may not always be 100% accurate.